Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine Pathology
Published in: Endocrine Pathology 1/1998

01-03-1998 | Short Communication

Columnar cell carcinoma of the thyroid: MIB-1 immunoreactivity as a prognostic factor

Authors: Mitsuyoshi Hirokawa, MD, PhD, Michio Shimizu, MD, PhD, Takashi Fukuya, MD, PhD, Toshiaki Manabe, MD, PhD, Hiroshi Sonoo, MD, PhD

Published in: Endocrine Pathology | Issue 1/1998

Login to get access
Metadata
Title
Columnar cell carcinoma of the thyroid: MIB-1 immunoreactivity as a prognostic factor
Authors
Mitsuyoshi Hirokawa, MD, PhD
Michio Shimizu, MD, PhD
Takashi Fukuya, MD, PhD
Toshiaki Manabe, MD, PhD
Hiroshi Sonoo, MD, PhD
Publication date
01-03-1998
Publisher
Humana Press
Published in
Endocrine Pathology / Issue 1/1998
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/BF02739949

Other articles of this Issue 1/1998

Endocrine Pathology 1/1998 Go to the issue

Clinical Research

Adrenocorticotropin-producing pituitary carcinoma with expression ofc-erbB-2 and high PCNA index: A comparative study with pituitary adenomas and normal pituitary tissues

Erratum

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in pituitary adenoma: Possible markers of endocrine cell

Case Report

Concurrent pheochromocytoma, paraganglioma, papillary thyroid carcinoma, and desmoid tumor: A case report with analyses at the molecular level

Clinical Research

Prevalence and prognostic significance of neuroendocrine differentiation in colorectal carcinomas

Review

From endocrinology to intracrinology

Case Report

Pituitary adenoma with cholesterol clefts
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits